Advertisement
Advertisement

HALO

HALO logo

Halozyme Therapeutics, Inc.

71.80
USD
Sponsored
-1.54
-2.10%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

71.81

+0.01
+0.02%

Halozyme Therapeutics, Inc. Financial Snapshot

Market Cap
8.44B
Beta
0.94
Earnings Per Share (EPS)
4.75
Price-to-Book (P/B) Ratio
17.11
Operating Margin
53.12%
Total Debt/Equity (D/E)
299.80%
P/E Ratio
13.79
Return on Equity (ROE)
156.95%
Current Ratio
1.59%
Free Cash Flow
875.86M

Earnings Chart

Trending Stocks

Advertisement